An interventional study of Low Vision Rehabilitation in Low Vision and Low Vision Aids, sponsored by University of California, Los Angeles. Recruiting at 9 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-24.
Sponsored by University of California, Los Angeles · Not applicable, Interventional, and Treatment
One goal of this research is to conduct a non-inferiority trial of telerehabilitation versus in-office care to provide follow-up training to individuals with low vision to enhance their quality of life by using magnification devices and/or visual assistive mobile apps for important daily activities, such as reading and/or other valued tasks. This is a high priority given the increasing prevalence of low vision, paucity of low vision rehabilitation providers, and barriers related to access to care, such as transportation and geography, which can be essentially eliminated with telerehabilitation. Another goal of this project is to determine whether significant changes in environmental data collected by Bluetooth low energy beacon sensors can be used as a solution to monitor and indicate when low vision patients' have abandoned the use of their magnification devices, which has the potential to substantially enhance patient management by providing timely low vision rehabilitation services.
98 studies on the registry are indexed under Vision, Low; 23 are open to participants now.
This study's planned enrollment of 350 is above the median of 60 across 78 interventional studies indexed under Vision, Low.
Browse Vision, Low studies →University of California, Los Angeles is the lead sponsor of 1,170 studies on the registry; 195 are open to participants now.
Of its 95 completed or terminated interventional studies of FDA-regulated products, 70 (74%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Low Vision Rehabilitation for use of magnification or visual assistive devices using videoconferencing for remotely delivered follow-up care
Behavioral: Low Vision Rehabilitation
Low Vision Rehabilitation in-office for use of magnification or visual assistive devices
Behavioral: Low Vision Rehabilitation
Evaluation and training with magnification or visual assistive devices for visually-impaired adults
Activity Inventory
questionnaire; scores will be Rasch analyzed in logic units with higher or positive scores indicating less difficulty (i.e., improvement)
Time frame: changes from 1 month to 4 months to 8 months to 12 months to 13 months after receiving a magnification device
MNread
reading speed and acuity test
Time frame: baseline, 1 month, 4 months, 8 months, 12 months, 13 months
Sustained Silent Reading Test
prolonged reading test
Time frame: baseline, 1 month, 4 months, 8 months, 12 months, 13 months
International Reading Speed Text (IReST)
reading speed test
Time frame: baseline, 1 month, 4 months, 8 months, 12 months, 13 months
Radner Reading Charts
reading speed and acuity test
Time frame: baseline, 1 month, 4 months, 8 months, 12 months, 13 months
Vision rehabilitation satisfaction survey
surveys: post-telerehabilitation or in-office visits
Time frame: after each session that will occur over a period of 1 to 8 months and and again at about 1 year
Informant surveys by close acquaintances of participants
survey
Time frame: 4 months, 8 months, 12 months, 13 months
Adherence to hand-held optical magnifier use (frequency and duration)
Bluetooth low energy beacon sensor data
Time frame: baseline to 13 months
Plan to share: Undecided — Please contact the principal investigator
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, Los Angeles →